Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Recursion Pharmaceuticals Inc
RXRX
Healthcare
Biotechnology
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative...
loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate in silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881 and REC-3964. REC-994 is an orally bioavailable, superoxide scavenger small molecule being development for the treatment of symptomatic cerebral cavernous malformation (CCM). REC-2282 for the potential treatment of neurofibromatosis type 2. REC-3964 for the prevention of recurrent Clostridioides difficile infection.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:RXRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(73)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on May 13, 2024 9:56am
RXRX: COMPLETED AN NVIDIA POWERED LARGEST SUPERCOMPUTER....
IN THE PHARMACEUTICAL INDUSTRY ... Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry Recursion Pharmaceuticals Mon, May 13, 2024, 5:00
...more
(73)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Apr 01, 2024 11:25pm
CATHIE WOOD NOW OWNS 22 MLN SHARES.
Source: Piotr Swat / Shutterstock.com https://finance.yahoo.com/news/cathie-wood-just-bought-3-190057515.htmlRecursion Pharmaceuticals (NASDAQ:RXRX) is using artificial intelligence (AI) to
...more
(73)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Mar 11, 2024 6:52pm
RXRX TO OPEN AN OFFICE IN LONDON ENGLAND & ADDED OXFORD
THEY ALSO ADDED AN OXFORD AI PROFESSOR TOTHE BOARD. AS WELL.. Recursion Announces Plans to Open New Office in London GlobeNewswireMar 11, 2024, 04:05 AM LONDON, March 11, 2024 (GLOBE
...more
(259)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 28, 2024 7:30pm
Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Toda
Breaking News: $RXRX Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today2024-02-28 18:44:00 ET Recursion Pharmaceuticals (NASDAQ: RXRX) couldn't get over the hump of Hump Day. Following
...more
(259)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 28, 2024 7:15pm
Recursion Pharmaceuticals Stock Is Sliding Wednesday: What's
BREAKING NEWS: $RXRX Recursion Pharmaceuticals Stock Is Sliding Wednesday: What's Going On? | BenzingaRecursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading lower Wednesday after the
...more
(7)
•••
jacobite
X
View Profile
View Bullboard History
Comment by
jacobite
on Feb 26, 2024 12:35pm
RE:RXRX is up 14% after hrs with good vol, i cant find any news
I have to think it's riding the NVDA tailwind after their buy in last summer
(73)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Feb 14, 2024 6:32pm
RXRX is up 14% after hrs with good vol, i cant find any news
anyone have any idea?
(73)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Jan 29, 2024 3:42pm
any thoughts whats' driving rxrx higher tdy?
it's kind of bizarre it's been on a down trend, daily lower highs and lower lows. suddenly up ??? help :)
(73)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Jan 29, 2024 3:22pm
rxrx director sells over 20K shares at 10.58 on jan 23
Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares RXRX +9.51% GuruFocus Research Thu, January 25, 2024 at 11:52 PM EST In this article: ·
...more
(49)
•••
Markcalgary
X
View Profile
View Bullboard History
Comment by
Markcalgary
on Jul 12, 2023 5:54pm
RE:Recursion Announces Collaboration and $50 Million Investment
$50M is peanuts for NVDA, but they would have looked around with keen eyes and picked RXRX. Part of it would be for the database for certain, but the timing of the buy-in co-incides with the closing
...more
(259)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jul 12, 2023 10:00am
Recursion Announces Collaboration and $50 Million Investment
NEWS: $RXRX Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug DiscoverySALT LAKE CITY, TORONTO and MONTR&
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario